Background Dry eye is a common disease worldwide, and animal models are critical for the study of it. At present, there is no research about the stability of the extant animal models, which may have negative implications for previous dry eye studies. In this study, we observed the stability of a rabbit dry eye model induced by the topical benzalkonium chloride (BAC) and determined the valid time of this model. Methods and Findings Eighty white rabbits were randomly divided into four groups. One eye from each rabbit was randomly chosen to receive topical 0.1% BAC twice daily for 2 weeks (Group BAC-W2), 3 weeks (Group BAC-W3), 4 weeks (Group BAC-W4), or 5 weeks (Group BAC-W5). Fluorescein staining, Schirmer's tests, and conjunctival impression cytology were performed before BAC treatment (normal) and on days 0, 7, 14 and 21 after BAC removal. The eyeballs were collected at these time points for immunofluorescence staining, hematoxylin and eosin (HE) staining, and electron microscopy. After removing BAC, the signs of dry eye in Group BAC-W2 lasted one week. Compared with normal, there were still significant differences in the results of Schirmer's tests and fluorescein staining in Groups BAC-W3 and BAC-W4 on day 7 (P<0.05) and in Group BAC-W5 on day 14 (P<0.05). Decreases in goblet cell density remained stable in the three experimental groups at all time points (P<0.001). Decreased levels of mucin-5 subtype AC (MUC5AC), along with histopathological and ultrastructural disorders of the cornea and conjunctiva could be observed in Group BAC-W4 and particularly in Group BAC-W5 until day 21. Conclusions A stable rabbit dry eye model was induced by topical 0.1% BAC for 5 weeks, and after BAC removal, the signs of dry eye were sustained for 2 weeks (for the mixed type of dry eye) or for at least 3 weeks (for mucin-deficient dry eye).
References
[1]
Lemp MA (1995) Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. Clao J 21: 221–232.
[2]
Hikichi T, Yoshida A, Fukui Y, Hamano T, Ri M, et al. (1995) Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol 233: 555–558.
[3]
Schein OD, Mu？oz B, Tielsch JM, Bandeen-Roche K, West S (1997) Prevalence of dry eye among the elderly. Am J Ophthalmol 124: 723–728.
[4]
Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, et al. (2003) Prevalence of dry eye among an elderly chinese population in Taiwan - The Shihpai eye study. Ophthalmology 110: 1096–1101.
[5]
No authors listed (2007) The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5: 75–92.
[6]
Susi B, Luana P, Patrizia C, Saettone MF, Boldrini E (1999) Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes[J]. Ophthalmic Res 31: 229–235.
[7]
Barabino S, Shen L, Chen L, Rashid S, Rolando M, et al. (2005) The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 46: 2766–2771.
[8]
Barabino S, Rolando M, Chen L, Dana MR (2007) Exposure to a dry environment induces strain-specific responses in mice. Exp Eye Res 84: 973–977.
[9]
Fabiani C, Barabino S, Rashid S, Dana MR (2009) Corneal epithelial proliferation and thickness in a mouse model of dry eye. Exp Eye Res 89: 166–171.
[10]
Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, et al. (2002) A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 43: 632–638.
[11]
Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, et al. (2006) Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol 176: 3950–3957.
[12]
Yeh S, Song XJ, Farley W, Li DQ, Stern ME, et al. (2003) Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 44: 124–129.
[13]
Stewart P, Chen Z, Farley W, Olmos L, Pflugfelder SC (2005) Effect of experimental dry eye on tear sodium concentration in the mouse. Eye Contact Lens 31: 175–178.
[14]
Luo L, Li DQ, Doshi A, Farley W, Corrales RM, et al. (2004) Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 45: 4293–4301.
[15]
Qu Jia, Chen Wei, Chen J, Wang S, et al. (2008) A Murine Model of Dry Eye Induced by an Intelligently Controlled Environmental System. Invest Ophthalmol Vis Sci 49: 1386–1391.
[16]
Chen W, Zhang X, Liu M, Zhang J, Ye Y, et al. (2009) Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res 89: 311–318.
[17]
Xiong C, Chen D, Liu J, Liu B, Li N, et al. (2008) A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 49: 1850–1856.
[18]
Sullivan DA (1986) Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res 42: 131–139.
[19]
Sullivan DA, Bloch KJ, Allansmith MR (1984) Hormonal influence on the secretory immune system of the eye: androgen regulation of secretory component levels in rat tears. Immunology 52: 234–246.
[20]
Gilbard JP, Rossi SR, Gray KL, Hanninen LA, Kenyon KR (1988) Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 29: 374–378.
[21]
Kaswan RL, Salisbury MA, Ward DA (1989) Spontaneous canine keratoconjunctivitis sicca: a useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. Arch Ophthalmol 107: 1210–1216.
[22]
Maitchouk DY, Beuerman RW, Ohta T, Stern M, Varnell RJ (2000) Tear production after unilateral removal of the main lacrimal gland insquirrel monkeys. Arch Ophthalmol 118: 246–252.
[23]
Fujihara T, Nagano T, Nakamura M, Shirasawa E (1995) Establishment of a rabbit short-term dry eye model. J Ocul Pharmacol Ther 11: 503–508.
[24]
Kunert KS, Tisdale AS, Gipson IK (2002) Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 120: 330–337.
[25]
Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29: 312–334.
[26]
Uematsu Masafumi, Kumagami Takeshi, Kusano M, Yamada K, Mishima K, et al. (2007) Acute corneal epithelial change after instillation of BAC evaluated using a newly developed in vivo cornea. Ophthalmic Res 39: 308–314.
[27]
Wilson G, Ren H, Laurent J (1995) Corneal epithelial fluorescein staining. J Am Optom Assoc 66: 435–441.
[28]
Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A (1997) Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci 38: 1458–1464.
[29]
Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P (1992) Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. BrJ Ophthalmol 76: 545–549.
[30]
Steuhl KP, Knorr M, Frohn A, Thiel HJ (1991) Effect of anti-glaucoma eyedrops on cell differentiation of the conjunctiva. Fortschr Ophthalmol 88: 865–869.
[31]
Ishibashi T, Yokoi N, Kinoshita S (2003) Comparison of the short-term effects on the human corneal surface of topical timolo maleate with and without benzalkonium chloride. J Glaucoma 12: 486–490.
[32]
Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, et al. (2004) Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 111: 2186–2192.
[33]
Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, et al. (2008) The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 115: 109–115.).
[34]
Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, et al. (2004) Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 45: 1360–1368.
[35]
De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, et al. (1999) Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 40: 619–30.
[36]
Green K, Chapman JM, Cheeks L (1987) Detergent penetration into young and adult rabbit eyes: comparative pharmacokinetics. Toxicol Cut Ocul Toxicol 6: 89–107.
[37]
Watanabe H (2002) Significance of mucin on the ocular surface. Cornea 21: 17–22.
[38]
Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, et al. (1998) Histopathological effects of topical ophthalmic preservatives on ratcorneoconjunctival surface. Curr Eye Res 17: 419–425.
[39]
Spurr-Michaud S, Argueso P, Gipson I (2007) Assay of mucins in human tear fluid. Exp Eye Res 84: 939–950.
